Michael Oettel
24Patents
10h-index
60Co-inventors
78Inventor score
Filing activity: Jul 18, 1977 → Jul 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5633242A | Pharmaceuticals for contraception/hormone substitution containing a biogenous estrogen component | Human Necessities | 92 | Expired |
| US5855905A | Compound preparation for the treatment of hypogonadal men and men with hypophyseal diseases | Human Necessities | 85 | Expired |
| US6133251A | Combination compound for contraception based on natural estrogen | Human Necessities | 60 | Expired |
| US6977083B1 | Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same | Human Necessities | 43 | Expired |
| US7025979B2 | Male contraceptive formulation comprising norethisterone | Human Necessities | 42 | Expired |
| US5795883A | Androgens and anabolic agents | Chemistry; Metallurgy | 34 | Expired |
| US5693628A | 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds | Chemistry; Metallurgy | 22 | Expired |
| US6245756A | Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system | Human Necessities | 19 | Expired |
| US5576310A | 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds | Chemistry; Metallurgy | 12 | Expired |
| US6225299A | Hormonal agent for skin treatment | Human Necessities | 12 | Expired |
| US6214377A | Melatonin for the production of a peroral pulsatile form of medication | Human Necessities | 8 | Expired |
| US5910493A | Hormonal agent for skin treatment | Human Necessities | 8 | Expired |
| US5914325A | Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances | Chemistry; Metallurgy | 7 | Expired |
| US6884793B2 | Combination preparation for contraception based on natural estrogens | Human Necessities | 4 | Expired |
| US6172056A | Pharmaceutical compositions and method for prophylaxis and therapy of radical-mediated cell damage | Human Necessities | 4 | Expired |
| US7053077B1 | Use of biogenic estrogen sulfamates for hormone replacement therapy | Human Necessities | 4 | Expired |
| US4231946A | 14,15-Methylene derivatives of the estrane series and methods for preparing same | Human Necessities | 3 | Expired |
| US6670350B1 | Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same | Human Necessities | 3 | Expired |
| US5977096A | Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances | Chemistry; Metallurgy | 2 | Expired |
| US4167517A | Gona-4,9(10)-dienes and process of producing the same | Chemistry; Metallurgy | 2 | Expired |
| US5614213A | Use of estriol for treatment of climacteric osteoporosis | Human Necessities | 1 | Expired |
| US5866559A | 17.alpha.-cyanomethylestra-4,9-dien derivatives and pharmaceutical compositions containing same | Chemistry; Metallurgy | 0 | Expired |
| US6432939B1 | 17a-hydroxy-4-androstene-3-one and derivatives thereof | Chemistry; Metallurgy | 0 | Expired |
| US11679114B2 | Progestogen-only oral contraception | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.